/People

Zeev Zehavi

Investor

Advisor at ALIVE Israel HealthTech Fund

Petah Tikva, Israel

Writes $100K – $5M checks · typically $1.5M

Find your path to Zeev

378 people in our graph can introduce you to Zeev.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Rafael Beyar to introduce you to Zeev

You →Rafael · together at ALIVE Israel HealthTech Fund (2023–2026) →Zeev

Ask Jamie Chen to introduce you to Zeev

You →Jamie · 6 people · together at ALIVE Israel HealthTech Fund →Zeev

Ask Sam Okafor to introduce you to Zeev

You →Sam · 4 people · together at Johnson & Johnson →Zeev

Sign up to find every way you can get introduced to Zeev

  • Your email: the people you already email who know Zeev
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Zeev
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Zeev Zehavi is Vice President of Venture Investments at Johnson & Johnson Innovation – JJDC, where he has held multiple roles since 1999, including European representative from 2007 to 2015 covering investments across pharmaceuticals, medical devices, and consumer health. Prior to joining JJDC, he spent over a decade at Teva Pharmaceutical Industries, serving as President of the bulk chemical business in North America, and subsequently led Clal Pharmaceutical Industries as President, overseeing private equity investments in generic R&D, drug delivery, and chiral chemistry. Zehavi holds a Bachelor of Science from Hebrew University of Jerusalem and an MBA in Marketing and Finance from Tel Aviv University, and currently serves as a Senior Advisor and Investment Committee member at the ALIVE Israel HealthTech Fund.

Experience

  1. ALIVE Israel HealthTech FundSenior Advisor Member of Investment Committeecurrent2023 — presentTel Aviv District, Israel
  2. Johnson & JohnsonVice President, Venture Investments, Johnson & Johnson Innovation — JJDC1999 — 2022
  3. Clal IndustriesPresident, Clal Pharmaceuticals1994 — 1998Israel
  4. Teva PharmaceuticalsPresident, Plantex USA1988 — 1993United States and Canada
  5. Teva PharmaceuticalsArea Export Sales Manager for Central America1983 — 1988Israel and Central America
  6. Israel Defense ForcesMilitary Service, Intelligence Forces1972 — 1978

Colleagues at ALIVE Israel HealthTech Fund

Frequently asked questions

Who is Zeev Zehavi?
Zeev Zehavi is Vice President of Venture Investments at Johnson & Johnson Innovation – JJDC, where he has held multiple roles since 1999, including European representative from 2007 to 2015 covering investments across pharmaceuticals, medical devices, and consumer health. Prior to joining JJDC, he spent over a decade at Teva Pharmaceutical Industries, serving as President of the bulk chemical business in North America, and subsequently led Clal Pharmaceutical Industries as President, overseeing private equity investments in generic R&D, drug delivery, and chiral chemistry. Zehavi holds a Bachelor of Science from Hebrew University of Jerusalem and an MBA in Marketing and Finance from Tel Aviv University, and currently serves as a Senior Advisor and Investment Committee member at the ALIVE Israel HealthTech Fund.
Where does Zeev Zehavi work?
Zeev Zehavi is Advisor at ALIVE Israel HealthTech Fund.
What check size does Zeev Zehavi write?
Zeev Zehavi typically writes checks of $100K – $5M.
Where did Zeev Zehavi go to school?
Zeev Zehavi studied at Tel Aviv University (Master of Business Administration - MBA, Recanati School of Management); The Hebrew University of Jerusalem (Bachelor of Science - BS, Faculty of Agriculture).

Same school

Shared employers